Fig. 3

Effects of ALC and differences in progression type upon prognosis. In the 37 patients with ALC ≥ 1500/μl, the PPL group had a better OS compared with the PNM group (B: p = 0.055, log-rank), but there was no significant difference in PFS between the two groups (A: p = 0.541, log-rank). On the other hand, in the 51 patients with ALC < 1500/μl, the PPL group had a significantly better prognosis than the PNM group (C: PFS p = 0.035, D: OS p < 0.001, log-rank, respectively)